144 related articles for article (PubMed ID: 15327888)
1. Prostate cancer and the met hepatocyte growth factor receptor.
Knudsen BS; Edlund M
Adv Cancer Res; 2004; 91():31-67. PubMed ID: 15327888
[TBL] [Abstract][Full Text] [Related]
2. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
Gmyrek GA; Walburg M; Webb CP; Yu HM; You X; Vaughan ED; Vande Woude GF; Knudsen BS
Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
[TBL] [Abstract][Full Text] [Related]
3. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
4. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
5. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
Davies G; Watkins G; Mason MD; Jiang WG
Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
[TBL] [Abstract][Full Text] [Related]
6. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
[TBL] [Abstract][Full Text] [Related]
7. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
Yu Y; Chen Y; Ding G; Wang M; Wu H; Xu L; Rui X; Zhang Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):154-60. PubMed ID: 26093299
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.
Nakashiro K; Hara S; Shinohara Y; Oyasu M; Kawamata H; Shintani S; Hamakawa H; Oyasu R
Am J Pathol; 2004 Aug; 165(2):533-40. PubMed ID: 15277227
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
[TBL] [Abstract][Full Text] [Related]
11. [A simple view on lung cancer biology: the MET pathway].
Ruppert AM; Beau-Faller M; Belmont L; Lavolé A; Gounant V; Cadranel J; Wislez M
Rev Mal Respir; 2011 Dec; 28(10):1241-9. PubMed ID: 22152933
[TBL] [Abstract][Full Text] [Related]
12. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
Ghatak S; Hascall VC; Markwald RR; Misra S
J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
14. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
[TBL] [Abstract][Full Text] [Related]
15. Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion.
van Leenders G; van Balken B; Aalders T; Hulsbergen-van de Kaa C; Ruiter D; Schalken J
Prostate; 2002 May; 51(2):98-107. PubMed ID: 11948964
[TBL] [Abstract][Full Text] [Related]
16. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
17. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
Accornero P; Martignani E; Macchi E; Baratta M
J Dairy Sci; 2007 Sep; 90(9):4289-96. PubMed ID: 17699048
[TBL] [Abstract][Full Text] [Related]
20. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
